Exact Sciences (EXAS) Tops Q2 EPS by 3c, Revs Miss; Maintains Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/6/2026

1. MU
2. APTX:CN
3. FRBT
4. SPY
5. KRG
6. EROC
7. FFAI
8. SKA-B
9. SEER
10. ALAR

Go back to Exact Sciences (EXAS) Tops Q2 EPS by 3c, Revs Miss; Maintains Outlook

Cologuard® revenue increased 78 percent to $103 million during second quarter

August 1, 2018 4:05 PM EDT

MADISON, Wis., Aug. 1, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company generated revenue of $102.9 million and completed approximately 215,000 Cologuard tests during the quarter ended June 30, 2018. Second-quarter 2018 revenue and Cologuard test volume grew by 78 percent and 59 percent, respectively, from the same period of 2017.

... More